Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT)

D. I. Rosenthal; P. M. Harari; J. Giralt; D. Bell; D. Raben; J. Liu; J. Schulten; K. K. Ang; J. A. Bonner

Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT)

D. I. Rosenthal, P. M. Harari, J. Giralt, D. Bell, D. Raben, J. Liu, J. Schulten, K. K. Ang, J. A. Bonner

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

8 Citations (Web of Science)

Original language	Undefined/Unknown
Journal	Journal of Clinical Oncology
Publication status	Published - 2014

Cite this

@article{ad8038532f7148d8bdfa4bd30bd57ee7,

title = "Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT)",

author = "Rosenthal, {D. I.} and Harari, {P. M.} and J. Giralt and D. Bell and D. Raben and J. Liu and J. Schulten and Ang, {K. K.} and Bonner, {J. A.}",

year = "2014",

language = "Indefinido/desconocido",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT)

AU - Rosenthal, D. I.

AU - Harari, P. M.

AU - Giralt, J.

AU - Bell, D.

AU - Raben, D.

AU - Liu, J.

AU - Schulten, J.

AU - Ang, K. K.

AU - Bonner, J. A.

PY - 2014

Y1 - 2014

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000358613203596&KeyUID=WOS:000358613203596

M3 - Artículo

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT)

Other files and links

Cite this